Early research (Phase 1)UnknownNCT04317209What this trial is testingSHR0410 in Hemodialysis Patients With PruritusWho this might be right forPruritus Jiangsu HengRui Medicine Co., Ltd. 54
Large-scale testing (Phase 3)Study completedNCT02210689What this trial is testingA Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant WomenWho this might be right forBACTERIAL VAGINOSISSigns and Symptoms to be Evaluated and Recorded IncludeVaginal Discharge Color, Odor, and Consistency+2 more Actavis Inc. 604
Large-scale testing (Phase 3)Study completedNCT03281538What this trial is testingExtension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe PruritusWho this might be right forUremic Pruritus Cara Therapeutics, Inc. 288
Post-approval studies (Phase 4)Looking for participantsNCT05042258What this trial is testingUsing Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic DermatitisWho this might be right forAtopic DermatitisSleep Disturbance Northwestern University 40
Testing effectiveness (Phase 2)Study completedNCT04018027What this trial is testingStudy to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic DermatitisWho this might be right forPruritusAtopic Dermatitis Cara Therapeutics, Inc. 401
Testing effectiveness (Phase 2)Study completedNCT04706975What this trial is testingStudy to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)Who this might be right forPruritusNotalgia Paresthetica Cara Therapeutics, Inc. 126
Large-scale testing (Phase 3)Study completedNCT01815424What this trial is testingA Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque PsoriasisWho this might be right forPsoriasis Pfizer 266
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06733519What this trial is testingTH104 for the Treatment of Pruritus in Primary Biliary CholangitisWho this might be right forPruritusPrimary Biliary Cholangitis Tharimmune Inc 40
Large-scale testing (Phase 3)Looking for participantsNCT06446310What this trial is testingPhase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe PruritusWho this might be right forUremic Pruritus Qilu Pharmaceutical (Hainan) Co., Ltd. 194
Large-scale testing (Phase 3)Ended earlyNCT05356403What this trial is testingCR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe PruritusWho this might be right forChronic Kidney DiseasesPruritus Cara Therapeutics, Inc. 105
Large-scale testing (Phase 3)Study completedNCT03668613What this trial is testingStudy to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Chronic Plaque-type Psoriasis Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Ended earlyNCT04605094What this trial is testingEfficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis AstraZeneca 194
Large-scale testing (Phase 3)Ended earlyNCT05342623What this trial is testingEvaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe PruritusWho this might be right forChronic Kidney DiseasesPruritus Cara Therapeutics, Inc. 286
Post-approval studies (Phase 4)Study completedNCT05590585What this trial is testingDupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema TrialWho this might be right forModerate-to-Severe Atopic DermatitisAtopic Eczema Regeneron Pharmaceuticals 124
Large-scale testing (Phase 3)Study completedNCT02601703What this trial is testingTo Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)Who this might be right forAtopic Dermatitis Glenmark Pharmaceuticals Ltd. India 1,110
Large-scale testing (Phase 3)Study completedNCT03422653What this trial is testingEvaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)Who this might be right forUremic Pruritus Cara Therapeutics, Inc. 378
Testing effectiveness (Phase 2)Looking for participantsNCT06593392What this trial is testingSafety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe PruritusWho this might be right forPruritusChronic Kidney Diseases Vifor Fresenius Medical Care Renal Pharma 18
Large-scale testing (Phase 3)Study completedNCT03066609What this trial is testingStudy of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forPlaque Psoriasis Novartis Pharmaceuticals 543
Testing effectiveness (Phase 2)Study completedNCT03100344What this trial is testingDose-ranging Study of Nemolizumab in Atopic DermatitisWho this might be right forAtopic Dermatitis Galderma R&D 226
Post-approval studies (Phase 4)Study completedNCT03440736What this trial is testingComparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic SyndromeWho this might be right forPsoriasisMetabolic Syndrome Novartis Pharmaceuticals 781